California State Teachers Retirement System grew its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 114,807.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 35,100,865 shares of the medical instruments supplier’s stock after buying an additional 35,070,318 shares during the period. California State Teachers Retirement System owned approximately 175.15% of Mettler-Toledo International worth $44,841,706,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of the business. Geneos Wealth Management Inc. boosted its holdings in Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock valued at $78,000 after purchasing an additional 30 shares during the period. Baird Financial Group Inc. raised its position in shares of Mettler-Toledo International by 3.1% in the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after buying an additional 40 shares in the last quarter. Jump Financial LLC boosted its stake in shares of Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after buying an additional 125 shares during the period. Cerity Partners LLC grew its position in Mettler-Toledo International by 10.8% during the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after buying an additional 392 shares in the last quarter. Finally, AXA S.A. grew its position in Mettler-Toledo International by 2.9% during the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after buying an additional 131 shares in the last quarter. 95.07% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth A number of research firms have recently weighed in on MTD. Robert W. Baird cut their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research report on Monday, May 11th. Jefferies Financial Group upped their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research report on Friday, July 31st. Weiss Ratings raised shares of Mettler-Toledo International from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 4th. Stifel Nicolaus boosted their target price on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, August 3rd. Finally, Rothschild & Co Redburn initiated coverage on shares of Mettler-Toledo International in a report on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price target for the company. Six research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and a consensus target price of $1,445.31.
Check Out Our Latest Stock Report on Mettler-Toledo International Insider Transactions at Mettler-Toledo International In other Mettler-Toledo International news, insider Gerry Keller sold 240 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $1,427.14, for a total value of $342,513.60. Following the completion of the transaction, the insider directly owned 259 shares in the company, valued at approximately $369,629.26. This trade represents a 48.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Thomas P. Salice sold 417 shares of Mettler-Toledo International stock in a transaction dated Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total value of $600,650.97. Following the sale, the director directly owned 292 shares in the company, valued at $420,599.72. The trade was a 58.82% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 4,254 shares of company stock worth $6,092,712. Insiders own 0.71% of the company’s stock.
Mettler-Toledo International Price Performance MTD stock opened at $1,344.87 on Monday. The stock has a market cap of $26.95 billion, a price-to-earnings ratio of 30.27, a P/E/G ratio of 2.70 and a beta of 1.22. The company has a debt-to-equity ratio of 159.45, a current ratio of 1.12 and a quick ratio of 0.78. The company has a 50 day simple moving average of $1,361.63 and a 200 day simple moving average of $1,274.11. Mettler-Toledo International, Inc. has a 1 year low of $1,023.05 and a 1 year high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last issued its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The company’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the business posted $10.09 earnings per share. Research analysts anticipate that Mettler-Toledo International, Inc. will post 47.35 EPS for the current fiscal year.
(Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Recommended Stories Five stocks we like better than Mettler-Toledo International AI Token Costs Are Changing the Hardware vs. Software Debate 3 ETFs That Could Move as Rate Expectations Shift 3 Stocks With September Catalysts Investors Shouldn’t Ignore Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
Bank of Nova Scotia purchased a new stake in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 3,306 shares of the medical instruments supplier’s stock, valued at approximately $4,223,000.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Aware Super Pty Ltd as trustee of Aware Super acquired a new stake in Mettler-Toledo International in the first quarter worth $26,372,000. Strs Ohio grew its holdings in shares of Mettler-Toledo International by 2,594.8% in the 4th quarter. Strs Ohio now owns 13,393 shares of the medical instruments supplier’s stock valued at $18,672,000 after buying an additional 12,896 shares during the period. Crossmark Global Holdings Inc. grew its holdings in shares of Mettler-Toledo International by 34.3% in the 4th quarter. Crossmark Global Holdings Inc. now owns 4,150 shares of the medical instruments supplier’s stock valued at $5,786,000 after buying an additional 1,060 shares during the period. SEB Asset Management AB bought a new stake in shares of Mettler-Toledo International in the 1st quarter valued at $15,889,000. Finally, Fifth Third Bancorp raised its stake in Mettler-Toledo International by 377.3% during the 1st quarter. Fifth Third Bancorp now owns 4,181 shares of the medical instruments supplier’s stock worth $5,272,000 after buying an additional 3,305 shares during the period. Institutional investors own 95.07% of the company’s stock.
Insiders Place Their Bets
In other Mettler-Toledo International news, CFO Shawn Vadala sold 2,240 shares of the business’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the sale, the chief financial officer owned 5,579 shares of the company’s stock, valued at approximately $7,989,128. The trade was a 28.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Gerry Keller sold 240 shares of the stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total value of $342,513.60. Following the completion of the transaction, the insider owned 259 shares of the company’s stock, valued at $369,629.26. This represents a 48.10% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 3,312 shares of company stock worth $4,750,362 over the last three months. Insiders own 0.71% of the company’s stock.
Mettler-Toledo International Stock Performance
NYSE MTD opened at $1,402.64 on Wednesday. The firm has a 50-day moving average of $1,329.55 and a 200-day moving average of $1,273.83. The company has a debt-to-equity ratio of 159.45, a quick ratio of 0.78 and a current ratio of 1.12. The stock has a market cap of $28.11 billion, a PE ratio of 31.57, a P/E/G ratio of 2.88 and a beta of 1.23. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, topping analysts’ consensus estimates of $10.78 by $0.68. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The company’s revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the firm earned $10.09 earnings per share. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 47.35 EPS for the current year.
Analyst Upgrades and Downgrades
Several equities analysts have recently weighed in on MTD shares. Stifel Nicolaus lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, August 3rd. Barclays increased their target price on Mettler-Toledo International from $1,300.00 to $1,575.00 and gave the stock an “overweight” rating in a research note on Monday, August 3rd. Robert W. Baird cut their price target on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Wolfe Research started coverage on shares of Mettler-Toledo International in a report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Finally, Morgan Stanley increased their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Tuesday, August 4th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $1,461.27.
Read Our Latest Stock Analysis on MTD
(Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Read More
Five stocks we like better than Mettler-Toledo International
Pathward’s Credit Scare Tests Its Comeback Story
Wiring the AI Boom: Rumble’s $13.7B Pivot
StoneX: Too Far Too Fast?
DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
Investors might want to bet on Mettler-Toledo (MTD - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.
Individual investors often find it hard to make decisions based on rating upgrades by Wall Street analysts, since these are mostly driven by subjective factors that are hard to see and measure in real time. In these situations, the Zacks rating system comes in handy because of the power of a changing earnings picture in determining near-term stock price movements.
Therefore, the Zacks rating upgrade for Mettler-Toledo basically reflects positivity about its earnings outlook that could translate into buying pressure and an increase in its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Mettler-Toledo imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for Mettler-ToledoThis maker of precision instruments is expected to earn $47.35 per share for the fiscal year ending December 2026, which represents no year-over-year change.
Analysts have been steadily raising their estimates for Mettler-Toledo. Over the past three months, the Zacks Consensus Estimate for the company has increased 1.6%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Mettler-Toledo to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Shawn Vadala, the chief financial officer of Mettler-Toledo International Inc. (MTD -0.14%), executed a sale of 2,240 shares on August 3, according to an SEC Form 4 filing.
Transaction summaryMetricValueShares sold2,240Transaction value$3.2 millionPost-transaction shares (directly held)5,579Post-transaction value$8.06 millionTransaction value based on SEC Form 4 weighted average sale price ($1,432); post-transaction value based on the August 3 market close ($1445).
Key questionsWhat were the mechanics of this transaction?
The sale was a non-discretionary liquidation of equity following the exercise of 2,240 stock options that were granted with a five-year annual vesting schedule.How does the execution price compare to the market valuation?
The shares were sold at $1,432 per share, while the stock was priced at $1,445 at the August 3 market close; the company has recorded a close to 20% gain over the one-year period ending on the transaction date.What is the insider's remaining financial interest in the firm?
Following this transaction, Shawn Vadala retains a direct ownership stake of 0.03% in the company, which carries a market capitalization of $29.0 billion.What is the company's current financial profile?
Mettler-Toledo International reported trailing twelve-month revenue of $4.1 billion and net income of $905.6 million as of the August 4 market close.Company OverviewMetricValueShare Price (as of market close 2026-08-04)$1,437.00Market Capitalization$29.0 billionRevenue (TTM)$4.1 billionNet Income (TTM)$905.6 millionCompany SnapshotMettler-Toledo International Inc. manufactures and distributes precision instruments and related services for laboratory, analytical, and industrial applications, generating revenue across its diversified product portfolio that serves scientific research, quality assurance, and process control functions globally.The company operates a geographically diversified business model with five regional divisions spanning the United States, Switzerland, Western Europe, China, and other international markets, enabling localized service delivery and market penetration across developed and emerging economies.The company serves a broad customer base, including pharmaceutical manufacturers, chemical producers, academic research institutions, food and beverage processors, and industrial enterprises that require precision measurement and analytical solutions for quality control and research applications.Mettler-Toledo International Inc. is a global leader in precision instrumentation with a market capitalization of $29 billion and TTM revenues of $4.1 billion, demonstrating substantial scale in the medical diagnostics and research sector. The company's strategic geographic diversification and comprehensive product portfolio position it to capture growth opportunities across multiple end markets while maintaining operational efficiency through regional manufacturing and distribution networks. With TTM net income of $905.6 million, the company demonstrates strong profitability and operational leverage in its core precision measurement and analytical instrumentation business.
What this transaction means for investorsVadala exercised options and sold the resulting shares just days after Mettler-Toledo delivered a beat-and-raise quarter, converting a portion of a five-year grant into cash while the stock traded near $1,440, a high share price reflecting a company that has never split its stock. He sold a touch below the day's close and remains a small fractional owner, so this is a finance chief effectively harvesting a maturing grant into strength, not a signal about what comes next.
The quarter he sold into was strong. Mettler-Toledo grew second-quarter revenue by about 4% to just over $1 billion and lifted adjusted earnings 14% to $11.46 a share, thanks in large part to strong China sales. One number to keep in view is that gross margin got a lift from a one-time $52.4 million tariff refund, so the underlying margin was not quite as strong as the headline, and that boost will not repeat next quarter, but ultimately, the company raised its full-year outlook, and CEO Patrick Kaltenbach pointed to "better-than-expected organic sales growth across our portfolio."
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Thomas P. Salice, a director at Mettler-Toledo International Inc. (MTD -0.14%), sold 415 shares of common stock on August 3, following the exercise of stock options, according to an SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$599,517Shares sold (directly held)415Post-transaction shares (directly held)292Post-transaction shares (indirectly held)52,492Post-transaction value$76.3 millionTransaction value based on SEC Form 4 weighted average sale price ($1444.62); post-transaction value based on August 3 market close ($1445.00).
Key questionsHow was this transaction structured?
The transaction was executed as a same-day exercise and sale, where 415 options with an exercise price of $397.95 were converted to common stock and immediately sold at a weighted average price of $1,444.62.What is the breakdown of the insider's remaining indirect holdings?
Salice retains control over 52,492 shares held indirectly through SRB Investments LLC (19,427 shares) and Teaghlach LLC (33,065 shares), the latter of which is fully owned and controlled with his spouse.What has been the performance of the stock leading up to this transaction?
Mettler-Toledo International shares generated a 20% one-year total return as of the August 3 transaction date, and as of the August 4, 2026 market close, the stock was priced at $1,437.00.Does the insider retain any additional equity incentives?
Yes, the director continues to hold 417 direct derivative securities following this exercise, ensuring continued participation in the company's future equity performance alongside his remaining common stock position.Company OverviewMetricValueShare Price (as of market close 2026-08-04)$1,437.00Market Capitalization$29.0 billionRevenue (TTM)$4.1 billionNet Income (TTM)$905.6 millionCompany SnapshotMettler-Toledo International Inc. manufactures and distributes precision instruments and related services for laboratory, analytical, and industrial applications, generating revenue across its diversified product portfolio that serves scientific research, quality assurance, and process control functions globally.The company operates a geographically diversified business model with five regional divisions spanning the United States, Switzerland, Western Europe, China, and other international markets, enabling localized service delivery and market penetration across developed and emerging economies.The company serves a broad customer base, including pharmaceutical manufacturers, chemical producers, academic research institutions, food and beverage processors, and industrial enterprises that require precision measurement and analytical solutions for quality control and research applications.Mettler-Toledo International Inc. is a global leader in precision instrumentation with a market capitalization of $29.0 billion and TTM revenues of $4.1 billion, demonstrating substantial scale in the medical diagnostics and research sector. The company's strategic geographic diversification and comprehensive product portfolio position it to capture growth opportunities across multiple end markets while maintaining operational efficiency through regional manufacturing and distribution networks. With TTM net income of $905.6 million, the company demonstrates strong profitability and operational leverage in its core precision measurement and analytical instrumentation business.
What this transaction means for investorsThe options behind Salice's sale were struck at $397.95, so against a stock near $1,445, Salice was converting a grant that had more than tripled in value, which is the kind of deep gain that comes from holding equity through years of compounding (notably, he’s been a director since October 1996). Plus, he exercised and sold only a small block and kept more than 52,000 shares across two investment entities.
More importantly for long-term investors, the company gave him a firm quarter to sell into. Mettler-Toledo grew organic sales about 4% last quarter, ahead of its own guidance, and lifted adjusted earnings 14% to $11.46 a share, with particular strength in China, the firm noted. It also raised its full-year outlook and increased its planned buyback to $875 million. That buyback is a quiet engine of Mettler-Toledo's returns, since the company has shrunk its share count meaningfully over the years, thereby lifting per-share earnings even when sales grow at a mid-single-digit pace. That steady math is a large part of why the stock trades where it does, and it’s more notable for investors than a sale like this one.
Read Next
About the Author
Jonathan Ponciano is a contributing stock market analyst at The Motley Fool. He has nearly a decade of experience as a financial journalist, most recently as an editor and senior reporter at Forbes focused on markets, technology, and entrepreneurship. Jonathan has also written for Investopedia and the Los Angeles Business Journal. He holds a dual B.A. in Business Journalism and Economics from the University of North Carolina at Chapel Hill and an M.B.A. from Columbia Business School. A North Carolina native now based in New York City, Jonathan has also lived in Mexico City and Los Angeles.
Head of Process Analytics Gerry Keller reported a sale of 240 shares of Mettler-Toledo International Inc. (MTD -0.14%) on August 3, following a derivative exercise, according to a recent SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$342,514Shares sold (direct)240Post-transaction shares (directly held)259Post-transaction value$374,255.00Transaction value based on SEC Form 4 weighted average sale price ($1,427.14); post-transaction value based on the August 3 market close ($1,445.00).
Key questionsWhat were the structural mechanics of this transaction?
The transaction was a same-day exercise and sale, where Keller converted 240 derivative instruments into common stock at a strike price of $720.81 before liquidating them on the open market. The underlying options were part of a grant that vested annually in five equal installments.What is the executive's remaining equity exposure?
At the conclusion of this transaction, Keller maintains direct ownership of 259 shares with a market value of $374,255.00 based on the August 3 closing price, supplemented by 235 derivative securities. This represents an aggregate insider ownership stake of just 0.0013% in the company.How has the stock performed leading into this disposition?
Mettler-Toledo International shares achieved a one-year total return of about 20% as of the August 3 transaction date. As of the August 4 market close, shares were priced at $1,437.00.What is the current financial scale of the company?
The Columbus-based enterprise reported trailing 12-month revenue of $4.1 billion and net income of $905.6 million. With a market capitalization of $29.0 billion, the company operates across five geographical divisions serving global scientific and industrial precision instrument markets.Company OverviewMetricValueShare Price (as of market close 2026-08-04)$1,437.00Market Capitalization$29.0 billionRevenue (TTM)$4.1 billionNet Income (TTM)$905.6 millionCompany SnapshotMettler-Toledo International Inc. manufactures and distributes precision instruments and related services for laboratory, analytical, and industrial applications, generating revenue across its diversified product portfolio that serves scientific research, quality assurance, and process control functions globally.The company operates a geographically diversified business model with five regional divisions spanning the United States, Switzerland, Western Europe, China, and other international markets, enabling localized service delivery and market penetration across developed and emerging economies.The company serves a broad customer base, including pharmaceutical manufacturers, chemical producers, academic research institutions, food and beverage processors, and industrial enterprises that require precision measurement and analytical solutions for quality control and research applications.Mettler-Toledo International Inc. is a global leader in precision instrumentation with a market capitalization of $29.0 billion and TTM revenues of $4.1 billion, demonstrating substantial scale in the medical diagnostics and research sector. The company's strategic geographic diversification and comprehensive product portfolio position it to capture growth opportunities across multiple end markets while maintaining operational efficiency through regional manufacturing and distribution networks. With TTM net income of $905.6 million, the company demonstrates strong profitability and operational leverage in its core precision measurement and analytical instrumentation business.
What this transaction means for investorsWhat stands out here is how little stock Keller holds to begin with, roughly 500 shares once this sale settles, so this appears to be an executive who exercises options and largely sells as they vest rather than building a large position, which would make the filing routine by habit rather than a fresh decision. The shares came from options struck at $720.81 and sold near $1,445, a healthy gain on equity granted years ago, cashed in days after the company reported a strong quarter.
Mettler-Toledo grew organic sales by about 4% last quarter, ahead of guidance, and lifted adjusted earnings 14% to $11.46 a share, with China up 9% on double-digit industrial demand tied to onshoring and areas like battery production. CEO Patrick Kaltenbach called the China result "a very strong result versus the guidance we initially had." The pull toward reshored manufacturing and newer industrial segments is an important thread to watch, since those are the trends feeding the process and industrial demand that carried the quarter, and that’s ultimately what long-term investors should be more focused on with this stock.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Thomas P. Salice, a director at Mettler-Toledo International Inc. (MTD -0.14%), reported the sale of 417 shares of the company on August 5, according to an SEC Form 4 filing.
Transaction summaryMetricValueTransaction value$600,651Shares sold417Post-transaction shares (directly held)292Post-transaction shares (indirectly held)52,492Post-transaction value$75.03 millionTransaction value based on SEC Form 4 weighted average sale price ($1,440.41); post-transaction value based on the August 5 market close ($1,421.52).
Key questionsWhat was the technical structure of this transaction?
This was a non-discretionary exercise-and-sell transaction where Salice exercised 417 options at a strike price of $397.95 and immediately liquidated the resulting common stock at a weighted average price of $1,440.41.How is the director's remaining equity distributed?
While direct holdings were reduced to 292 shares, Salice retains beneficial ownership of 52,492 shares held indirectly through SRB Investments LLC and Teaghlach LLC. He also continues to hold derivative securities, though the exact quantity of remaining options was not disclosed in this filing.What is the company snapshot for Mettler-Toledo?
Mettler-Toledo is a global producer of precision instruments with a market capitalization of $28.7 billion. Its operations are organized across five geographical divisions, including Swiss, Western European, and Chinese operations, serving diverse scientific and industrial needs.How has the stock performed leading up to this transaction?
As of the August 5 transaction date, the company recorded a one-year total return of 14%, with shares priced at $1,421.24 as of the August 6 market close.Company OverviewMetricValueShare Price (as of market close 2026-08-06)$1,421.24Market Capitalization$28.7 billionRevenue (TTM)$4.1 billionNet Income (TTM)$905.6 millionCompany SnapshotMettler-Toledo International Inc. manufactures and distributes precision instruments and analytical solutions for laboratory, industrial, and research applications, with revenue generated across its diversified product portfolio serving scientific and industrial markets globally.The company operates a geographically diversified business model with strategic divisions across the United States, Switzerland, Western Europe, China, and other international territories, enabling localized market penetration and operational efficiency.The company serves pharmaceutical, biotechnology, academic research institutions, food and beverage manufacturers, and industrial enterprises that require precision measurement and analytical instrumentation for quality control and research applications.Mettler-Toledo International Inc. is a global leader in precision instrumentation with a market capitalization of $28.7 billion and TTM revenues of $4.1 billion, demonstrating substantial scale and market presence in the healthcare and industrial diagnostics sectors. The company's diversified geographical footprint and comprehensive product portfolio position it to capture demand across multiple end-markets, while its net income of $905.6 million reflects strong operational profitability and efficient capital deployment. With a one-year share price appreciation of 14%, the company has demonstrated resilient market performance and investor confidence in its strategic positioning.
What this transaction means for investorsThis is the second time in less than a week that Salice has run the same play, exercising options struck at $397.95 and selling the shares right away, so the two filings together amount to one old grant being cleared out rather than two separate calls on the stock. He left his large indirect position of more than 52,000 shares untouched, which is the tell that this is housekeeping on vested equity rather than a change of heart.
Meanwhile, Mettler-Toledo has been performing well. The firm grew organic sales by about 4% last quarter, ahead of its own guidance, and now expects full-year adjusted earnings of $47.15 to $47.50 a share, up 11% to 12% before currency, with free cash flow projected near $900 million. On the earnings call, CEO Patrick Kaltenbach said the company was "very pleased with our Q2 results and the solid growth our team has delivered." One thing to notice is that his second batch fetched less than his first, roughly $1,440 against $1,445 two days earlier, as the stock eased back from where it sat right after earnings. That doesn’t mean too much, but it’s a reminder of the type of catalysts that can rapidly shift sentiment, and for now, that sentiment is positively on Mettler-Toledo’s side.
Jonathan Ponciano has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Mettler-Toledo International, Inc. (NYSE:MTD – Get Free Report) Director Thomas Salice sold 417 shares of the company’s stock in a transaction on Wednesday, August 5th. The shares were sold at an average price of $1,440.41, for a total value of $600,650.97. Following the completion of the sale, the director owned 292 shares of the company’s stock, valued at approximately $420,599.72. This trade represents a 58.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Mettler-Toledo International Price Performance NYSE:MTD opened at $1,429.14 on Monday. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45. The business’s 50-day moving average price is $1,267.38 and its 200 day moving average price is $1,272.92. Mettler-Toledo International, Inc. has a 52-week low of $1,023.05 and a 52-week high of $1,525.17. The firm has a market cap of $28.64 billion, a P/E ratio of 32.17, a PEG ratio of 2.94 and a beta of 1.23.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last issued its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.03 billion. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. Mettler-Toledo International’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the company earned $10.09 EPS. As a group, sell-side analysts predict that Mettler-Toledo International, Inc. will post 47.35 earnings per share for the current fiscal year.
Institutional Inflows and Outflows Several large investors have recently bought and sold shares of MTD. Reflection Asset Management purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $26,000. Whipplewood Advisors LLC acquired a new position in Mettler-Toledo International in the 1st quarter valued at approximately $25,000. Elyxium Wealth LLC purchased a new stake in Mettler-Toledo International in the 4th quarter worth approximately $29,000. DV Equities LLC acquired a new stake in shares of Mettler-Toledo International during the 4th quarter valued at $40,000. Finally, Root Financial Partners LLC grew its holdings in shares of Mettler-Toledo International by 45.5% during the 1st quarter. Root Financial Partners LLC now owns 32 shares of the medical instruments supplier’s stock valued at $40,000 after acquiring an additional 10 shares in the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In Several research analysts have issued reports on the company. Citigroup dropped their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a report on Friday, May 8th. Weiss Ratings upgraded Mettler-Toledo International from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, August 4th. Wolfe Research initiated coverage on Mettler-Toledo International in a research report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Finally, Morgan Stanley increased their price target on Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Tuesday, August 4th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $1,461.27.
Read Our Latest Research Report on MTD
Mettler-Toledo International Company Profile (Get Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Read More Five stocks we like better than Mettler-Toledo International Albemarle’s Blowout Quarter Shows Why Lithium Still Matters Can DICK’S Turn Foot Locker Into a Winner? Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEInsider Selling: Linkhome (NASDAQ:LHAI) CEO Sells $500,000.00 in Stock
NEXT HEADLINE »Insider Selling: Sirius XM (NASDAQ:SIRI) Director Sells $499,659.84 in Stock
Empowered Funds LLC increased its position in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 63.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,722 shares of the medical instruments supplier’s stock after acquiring an additional 1,061 shares during the quarter. Empowered Funds LLC’s holdings in Mettler-Toledo International were worth $3,433,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Geneos Wealth Management Inc. increased its position in Mettler-Toledo International by 83.3% in the 1st quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after buying an additional 30 shares during the period. Baird Financial Group Inc. boosted its position in shares of Mettler-Toledo International by 3.1% in the second quarter. Baird Financial Group Inc. now owns 1,347 shares of the medical instruments supplier’s stock valued at $1,582,000 after acquiring an additional 40 shares during the period. Jump Financial LLC boosted its position in shares of Mettler-Toledo International by 44.6% in the second quarter. Jump Financial LLC now owns 405 shares of the medical instruments supplier’s stock valued at $476,000 after acquiring an additional 125 shares during the period. Cerity Partners LLC grew its stake in shares of Mettler-Toledo International by 10.8% in the second quarter. Cerity Partners LLC now owns 4,035 shares of the medical instruments supplier’s stock worth $4,740,000 after acquiring an additional 392 shares during the last quarter. Finally, AXA S.A. grew its stake in shares of Mettler-Toledo International by 2.9% in the second quarter. AXA S.A. now owns 4,625 shares of the medical instruments supplier’s stock worth $5,433,000 after acquiring an additional 131 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.
Key Headlines Impacting Mettler-Toledo International Here are the key news stories impacting Mettler-Toledo International this week:
Positive Sentiment: Q2 results and outlook beat expectations: Mettler-Toledo exceeded second-quarter EPS estimates, with sales growth led by China and emerging markets. Management also raised its 2026 sales and earnings outlook, providing the strongest catalyst for the stock’s advance. MTD Second Quarter Earnings Beat Estimates on China-Led Sales Growth Positive Sentiment: Analysts raised targets: Stifel lifted its target to $1,600 and maintained a Buy rating, while Barclays raised its target to $1,575 and retained an Overweight rating. The increases signal greater confidence in MTD’s earnings trajectory and leave additional implied upside based on the referenced share price. Analyst price-target updates Positive Sentiment: Board expanded with industrial-sector experience: Natalia Shuman, the CEO of MISTRAS Group, joined Mettler-Toledo’s Board of Directors effective August 3. Her background in technology-enabled industrial asset integrity solutions could add relevant operating and leadership expertise. Natalia Shuman Joins Mettler Toledo Board of Directors Neutral Sentiment: Wells Fargo raised its price target to $1,450 but kept an Equal Weight rating, indicating that the firm sees limited near-term upside at the referenced price despite acknowledging improved expectations. Wells Fargo raises MTD price target Neutral Sentiment: A separate report compares Mettler-Toledo with ImmunoPrecise Antibodies but provides no specific new operating, financial or valuation catalyst for MTD. Analyzing ImmunoPrecise Antibodies and Mettler-Toledo International Mettler-Toledo International Price Performance Mettler-Toledo International stock opened at $1,446.84 on Tuesday. The business has a 50 day simple moving average of $1,244.14 and a 200 day simple moving average of $1,274.25. The company has a debt-to-equity ratio of 159.45, a current ratio of 1.12 and a quick ratio of 0.78. The company has a market capitalization of $29.24 billion, a PE ratio of 32.56, a price-to-earnings-growth ratio of 2.92 and a beta of 1.23. Mettler-Toledo International, Inc. has a one year low of $1,023.05 and a one year high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $11.46 earnings per share for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. The firm had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%.The business’s revenue was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business posted $10.09 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. On average, sell-side analysts forecast that Mettler-Toledo International, Inc. will post 47.25 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth MTD has been the subject of a number of research reports. Stifel Nicolaus increased their price target on shares of Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday. Wall Street Zen downgraded shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a report on Saturday, May 16th. Citigroup reduced their target price on shares of Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Robert W. Baird lowered their price target on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Finally, JPMorgan Chase & Co. cut their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $1,445.36.
Check Out Our Latest Research Report on MTD
Mettler-Toledo International Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading Five stocks we like better than Mettler-Toledo International SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control Why Rare Earth Processing Could Be the Real 2027 Opportunity The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks? Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECalifornia State Teachers Retirement System Takes Position in IREN Limited $IREN
NEXT HEADLINE »AptarGroup, Inc. $ATR Stock Position Raised by California State Teachers Retirement System
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced today that Natalia Shuman has been appointed to its Board of Directors effective August 3, 2026.
Ms. Shuman has served as President and Chief Executive Officer of MISTRAS Group, a global leader in technology-enabled industrial asset integrity solutions, since January 2025 and is a member of its Board of Directors. Prior to joining MISTRAS, she was Executive Vice President and a member of the Group Operating Council of Eurofins Scientific, a leading global provider of analytical laboratory testing services. Previously, she served as Chief Executive Officer of Bureau Veritas North America from 2017 to 2021, following more than two decades in leadership roles at Kelly Services.
Roland Diggelmann, Chair of the Board, stated, “Natalia is a very accomplished business leader and brings over two decades of experience leading global organizations providing testing, inspection, and certification services for industrial, biopharma, and food companies, which are important markets for METTLER TOLEDO. Her perspectives on technology and digital enablement in service will also be highly valuable. We welcome Natalia and look forward to her contributions to our Board.”
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
Key Takeaways MTD beat Q2 earnings estimates as China and emerging markets drove organic sales growth.Mettler-Toledo expanded margins through pricing, productivity and lower tariffs despite higher costs.MTD raised 2026 sales growth and adjusted earnings guidance after the stronger second quarter. Mettler-Toledo International (MTD - Free Report) reported second-quarter 2026 adjusted earnings of $11.46 per share, which beat the Zacks Consensus Estimate of $10.78 by 6.31%. Adjusted earnings increased 14% year over year.
Net sales of $1.03 billion increased 4% year over year but missed the Zacks Consensus Estimate of $1.03 billion by 0.46%. Better-than-expected organic sales growth, including strong demand in China and emerging markets, supported the quarter.
MTD Navigates a More Favorable Regional BackdropOn a local-currency basis, MTD's sales increased 3% in the Americas, 4% in Europe and 10% in Asia/Rest of World in the quarter. Excluding acquisitions and one-time tariff refunds to customers, organic local-currency sales increased 4%, including 1% growth in the Americas and 9% growth in Asia/Rest of World.
By geography, Americas sales declined to $402 million from $414 million, accounting for 39% of total revenues. Europe sales increased to $294 million from $274 million and represented 29% of revenues, while Asia/Rest of World sales rose to $331 million from $295 million, contributing 32% of total revenues.
Mettler-Toledo Sees Strength Across BusinessesLaboratory sales increased to $553 million from $538 million in the prior-year quarter. Industrial sales improved to $418 million from $395 million, while Food Retail revenues increased to $57 million from $51 million.
On an organic local-currency basis, Laboratory sales increased 4%, Industrial sales rose 3%, including 4% growth in Core Industrial and 1% growth in Product Inspection, while Food Retail sales climbed 11%. Service revenues increased 9%, or 7% organically.
Management noted that China delivered 9% growth, supported by Industrial demand, while emerging markets outside China also posted high-single-digit growth. Improved conditions in biopharma, automation, semiconductor, batteries and food manufacturing markets also aided performance.
MTD Expands Margins Despite Higher ExpensesAdjusted gross profit increased to $625.7 million from $579.9 million. Adjusted gross margin expanded 30 basis points year over year to 59.3%, benefiting from pricing, lower tariff rates, productivity initiatives and volume growth, partly offset by higher transportation costs.
Research and development expenses increased to $53 million from $49.3 million. Selling, general and administrative expenses rose to $263.3 million from $247.3 million.
Adjusted operating profit increased 9% year over year to $309.3 million. Adjusted operating margin expanded 50 basis points to 29.3%. Reported diluted earnings per share were $11.55 compared with $9.76 in the prior-year quarter.
Mettler-Toledo Balance Sheet Remains SolidAs of June 30, 2026, cash and cash equivalents were $51.4 million compared with $60.5 million as of March 31, 2026. Long-term debt declined sequentially to $2.04 billion from $2.16 billion.
Year-to-date adjusted free cash flow totaled $367 million. Management noted that free cash flow was affected by the timing of tax payments, which were $55 million higher than the prior year.
The company also increased its planned share repurchases for 2026 to $875 million from the annualized first-half pace of $825 million.
MTD's Q3 & FY26 GuidanceManagement cautioned that market conditions remain uncertain and could change quickly, but guided for third-quarter 2026 local-currency sales growth of approximately 4%. Adjusted earnings for the third quarter are forecast to be in the range of $12-$12.15 per share, implying 8-9% growth year over year.
For 2026, MTD raised its local-currency sales growth outlook to approximately 4-5% from the prior view of approximately 4%, and raised adjusted earnings guidance to $47.15-$47.50 per share, representing growth of 10-11%, from the prior outlook of $46.30-$46.95.
Zacks Rank & Other Stocks to ConsiderMTD currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks in the broader Zacks Medical sector are Progyny (PGNY - Free Report) , Centene (CNC - Free Report) and GETINGE (GNGBY - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Shares of Progyny have surged 21.2% year to date. The Zacks Consensus Estimate for Progyny’s 2026 earnings is pegged at $2.04 per share, up by 3.55% over the past 30 days, indicating an increase of 7.94% year over year.
Shares of Centene have jumped 51.2% year to date. The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $4.71 per share, up 36.13% over the past 30 days, indicating a rise of 126.44% year over year.
GETINGE shares have appreciated 5.2% year to date. The Zacks Consensus Estimate for GETINGE’s 2026 earnings is pegged at $1.38 per share, up by 9.52% over the past 30 days, indicating an increase of 20% year over year.
Axiom Investment Management LLC acquired a new position in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 676 shares of the medical instruments supplier’s stock, valued at approximately $853,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Capital International Investors boosted its position in Mettler-Toledo International by 12.7% in the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock valued at $1,351,064,000 after buying an additional 109,508 shares in the last quarter. T. Rowe Price Investment Management Inc. increased its holdings in Mettler-Toledo International by 0.5% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock worth $964,174,000 after purchasing an additional 3,157 shares in the last quarter. Geode Capital Management LLC raised its position in Mettler-Toledo International by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock valued at $830,879,000 after purchasing an additional 14,106 shares during the last quarter. Norges Bank acquired a new stake in shares of Mettler-Toledo International during the fourth quarter valued at about $520,989,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Mettler-Toledo International by 0.4% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 272,829 shares of the medical instruments supplier’s stock valued at $380,375,000 after buying an additional 1,052 shares during the period. 95.07% of the stock is currently owned by institutional investors and hedge funds.
Mettler-Toledo International News Roundup Here are the key news stories impacting Mettler-Toledo International this week:
Positive Sentiment: Quarterly earnings beat expectations: Adjusted EPS rose 14% year over year to $11.46, exceeding the $10.80 consensus estimate by $0.66. Revenue increased approximately 4% to $1.03 billion, in line with expectations, while reported EPS reached $11.55 versus $9.76 a year earlier. Mettler-Toledo Second-Quarter 2026 Results Positive Sentiment: Full-year outlook was raised: Mettler-Toledo now expects fiscal 2026 EPS of $47.15 to $47.50, above the prior consensus estimate of $46.64. The updated outlook supports expectations for continued earnings growth and helped strengthen the investment case. Mettler-Toledo Second-Quarter 2026 Results Positive Sentiment: Jefferies became more bullish: Jefferies Financial Group raised its price target from $1,400 to $1,580 and upgraded the stock to “buy,” implying roughly 11% upside from the referenced trading level. The upgrade provides additional positive analyst momentum. Benzinga analyst-upgrade report Neutral Sentiment: Third-quarter guidance was broadly in line: EPS guidance of $12.00 to $12.15 brackets the $12.12 consensus estimate, while revenue guidance of approximately $1.1 billion is consistent with expectations. This suggests steady performance but provides less of a near-term upside surprise than the full-year outlook. Analysts Set New Price Targets A number of brokerages have weighed in on MTD. Wolfe Research initiated coverage on Mettler-Toledo International in a report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Weiss Ratings cut shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a research report on Tuesday, July 21st. JPMorgan Chase & Co. reduced their target price on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Citigroup decreased their target price on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Finally, Morgan Stanley dropped their price target on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 12th. Six analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to MarketBeat, Mettler-Toledo International has an average rating of “Hold” and an average target price of $1,420.36.
View Our Latest Stock Analysis on MTD
Mettler-Toledo International Trading Up 2.7% NYSE:MTD opened at $1,418.55 on Friday. The stock has a market capitalization of $28.67 billion, a PE ratio of 31.93, a price-to-earnings-growth ratio of 2.88 and a beta of 1.24. The firm’s 50 day moving average is $1,237.30 and its 200 day moving average is $1,276.04. Mettler-Toledo International, Inc. has a 12 month low of $1,023.05 and a 12 month high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Thursday, July 30th. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.80 by $0.66. Mettler-Toledo International had a negative return on equity of 872.07% and a net margin of 21.91%.The business had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period last year, the business posted $10.09 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 47.150-47.500 EPS and its Q3 2026 guidance at 12.000-12.150 EPS. Research analysts predict that Mettler-Toledo International, Inc. will post 46.63 earnings per share for the current year.
Mettler-Toledo International Company Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles Five stocks we like better than Mettler-Toledo International Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case Apple’s Record Quarter Could Not Outrun Its Guidance Problem McKesson’s Compounding Keeps Adding Up Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAxiom Investment Management LLC Makes New $869,000 Investment in GE Vernova Inc. $GEV
NEXT HEADLINE »Axiom Investment Management LLC Purchases New Stake in Blackstone Inc. $BX
For the quarter ended June 2026, Mettler-Toledo (MTD - Free Report) reported revenue of $1.03 billion, up 4.5% over the same period last year. EPS came in at $11.46, compared to $10.09 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $1.03 billion, representing a surprise of -0.46%. The company delivered an EPS surprise of +6.31%, with the consensus EPS estimate being $10.78.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Mettler-Toledo performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Net Sales- Products: $753 million compared to the $765.74 million average estimate based on two analysts. The reported number represents a change of +2.6% year over year.Net Sales- Service (Point in Time+Over Time): $274.31 million versus the two-analyst average estimate of $269.74 million. The reported number represents a year-over-year change of +10.2%.Net Sales- Retail: $57.06 million versus the two-analyst average estimate of $52.03 million. The reported number represents a year-over-year change of +12.6%.Net Sales- Industrial: $417.7 million versus $414.65 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +5.9% change.Net Sales- Laboratory: $552.55 million versus the two-analyst average estimate of $562.82 million. The reported number represents a year-over-year change of +2.7%.View all Key Company Metrics for Mettler-Toledo here>>>
Shares of Mettler-Toledo have returned +5.5% over the past month versus the Zacks S&P 500 composite's -0.5% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.
Matador’s Results Were Better Than Feared, But 2026 Headwinds Still MatterMettler-Toledo International NYSE: MTD reported second-quarter results that exceeded its prior sales-growth expectations, supported by improving market conditions, particularly in China and other emerging markets, as well as its sales and marketing initiatives.
Chief Executive Officer Patrick Kaltenbach said the company’s performance reflected “better-than-expected organic sales growth across our portfolio,” with strong execution of its Spinnaker sales and marketing program and productivity initiatives contributing to adjusted earnings-per-share growth.
Get MTD alerts:
3 Mid-Cap Energy Firms Analysts See Moving Up to the Big LeaguesSecond-quarter sales were $1 billion, up 7% in U.S. dollars and 6% in local currency. Acquisitions contributed about 1.5 percentage points of sales growth, while organic local-currency sales increased 4%.
The company said its reported results included a one-time $52 million gross benefit from IEEPA tariff refunds, which was recorded in cost of sales. That benefit was partly offset by a $28 million refund to customers that reduced reported net sales by 3%. Management excluded both tariff-refund items from its discussion of adjusted results and guidance.
Regional and Business-Line Performance 5 Highly Rated Dividends With 50% Upside According to AnalystsOrganic sales, excluding acquisitions and tariff refunds, increased 1% in the Americas, 4% in Europe and 9% in Asia/rest of world. China also grew 9%, exceeding management’s expectations.
Kaltenbach said China’s growth was led by Industrial, which posted double-digit growth in the country. Demand was supported by biopharma, food, batteries and new-energy investments. Laboratory growth in China was more modest, though the company expects further improvement in the second half.
By product area, organic sales in Laboratory increased 4%, while Industrial sales rose 3%. Core Industrial grew 4%, partially offset by 1% growth in Product Inspection. Food Retail sales increased 11%, aided by the timing of project activity, while service revenue rose 9%, or 7% organically.
Laboratory growth was broad-based, according to Kaltenbach. Process analytics and bioproduction performed strongly, while laboratory balances and analytical instruments benefited from newer product introductions. The company also cited demand for its LabX software platform and activity in semiconductors, advanced materials and batteries.
In Industrial, Mettler-Toledo saw strong demand for automation-related solutions across biopharma, food manufacturing, semiconductors and new energy. Product Inspection growth was modest because of customer-project timing, but Chief Financial Officer Shawn Vadala said the company expects organic growth in that business to improve in the second half. He projected mid-single-digit Product Inspection growth for the third quarter and high-single-digit growth for the full year, including acquisition contributions.
Margins, Earnings and Cash Flow Adjusted gross margin was 59.3%, up 30 basis points from a year earlier. Excluding foreign exchange and acquisitions, gross margin expanded about 90 basis points, driven by favorable price realization, lower tariff rates than the prior year, volume growth, productivity initiatives and cost savings. Those benefits were partly offset by higher transportation costs.
Adjusted operating profit rose 9% to $309 million, and adjusted operating margin increased 50 basis points to 29.3%. Excluding unfavorable currency, adjusted operating margin increased 100 basis points.
Adjusted EPS increased 14% year over year to $11.46. Reported EPS was $11.55, compared with $9.76 in the prior-year quarter. Reported EPS included a net tariff-refund benefit of $0.92, along with $0.26 of purchased intangible amortization, $0.22 of restructuring costs, a $0.04 tax headwind tied to stock-option exercise timing, and a $0.31 acquisition-related charge related to higher earn-out achievements.
Year-to-date adjusted free cash flow was $367 million, affected by tax payments that were $55 million higher than the prior year because of timing. The company reported days sales outstanding of 35.6 days and inventory turnover of 4.2 times.
Raised Full-Year Outlook Mettler-Toledo raised its 2026 local-currency sales-growth forecast to approximately 4% to 5%, from approximately 4% previously. The revised outlook implies 3% to 4% organic local-currency growth and excludes the tariff-refund effects.
Full-year adjusted EPS is projected at $47.15 to $47.50, representing growth of 10% to 11%, or 11% to 12% excluding currency. The prior full-year adjusted EPS outlook called for growth of 8% to 10%. Third-quarter local-currency sales growth is expected to be about 4%, including roughly a 0.5% benefit from acquisitions. Third-quarter adjusted EPS is forecast at $12.00 to $12.15, up 8% to 9%, or 9% to 10% excluding currency. Full-year free cash flow is expected to be approximately $900 million. The company now expects to repurchase $875 million of shares during 2026, compared with an annualized repurchase pace of $825 million in the first half. At recent spot rates, the company expects foreign currency to add about 1% to full-year sales growth but create a slight EPS headwind. Currency is expected to be neutral to third-quarter sales and reduce third-quarter adjusted EPS growth by roughly 1 percentage point.
Emerging Markets, Biopharma and Market Conditions Kaltenbach highlighted emerging markets as a long-term source of growth. Emerging markets outside China accounted for approximately 18% of second-quarter sales, slightly more than the company’s China business, and grew at a high-single-digit rate. Management said those markets have grown at a high-single-digit local-currency average over the past five years.
The company cited India, Southeast Asia, Eastern Europe and Latin America as areas of opportunity, including potential benefits from nearshoring investment. Kaltenbach said Mettler-Toledo’s local market organizations, direct sales capabilities, local manufacturing and assembly capabilities in markets such as Mexico, and global data infrastructure position it to pursue growth opportunities.
Management also said biopharma activity improved, particularly in process analytics and bioproduction. Kaltenbach said Mettler-Toledo is seeing requests for quotations tied to U.S. reshoring, but characterized the opportunity as still in its early stages. He said more substantial facility investments could extend into 2027 and 2028.
While the company acknowledged continued geopolitical uncertainty and volatile conditions in the Middle East, Vadala said Mettler-Toledo has limited exposure to the region and has not observed a related change in customer behavior. The company did not include an escalation of the conflict in its forecast.
“We remain focused on capitalizing on our customers’ investments in automation, digitalization, and onshoring around the world,” Kaltenbach said.
About Mettler-Toledo International (NYSE:MTD)Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company's product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Mettler-Toledo International Right Now?Before you consider Mettler-Toledo International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Mettler-Toledo International wasn't on the list.
While Mettler-Toledo International currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced second quarter results for 2026. Provided below are the highlights: Reported sales increased 4% compared with the prior year. In local currency, sales increased 6% excluding a one-time tariff refund to customers. Net earnings per diluted share as reported (EPS) were $11.55, compared with $9.76 in the prior-year period. Adjusted EPS was $11.46, an increase of 14% over the prior-year amount of $10.09. A.
Wall Street analysts expect Mettler-Toledo (MTD - Free Report) to post quarterly earnings of $10.78 per share in its upcoming report, which indicates a year-over-year increase of 6.8%. Revenues are expected to be $1.03 billion, up 5% from the year-ago quarter.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
In light of this perspective, let's dive into the average estimates of certain Mettler-Toledo metrics that are commonly tracked and forecasted by Wall Street analysts.
According to the collective judgment of analysts, 'Net Sales- Products' should come in at $765.74 million. The estimate indicates a change of +4.3% from the prior-year quarter.
It is projected by analysts that the 'Net Sales- Service (Point in Time+Over Time)' will reach $269.74 million. The estimate indicates a change of +8.3% from the prior-year quarter.
Analysts predict that the 'Net Sales- Retail' will reach $52.03 million. The estimate suggests a change of +2.7% year over year.
Based on the collective assessment of analysts, 'Net Sales- Industrial' should arrive at $414.65 million. The estimate points to a change of +5.1% from the year-ago quarter.
The average prediction of analysts places 'Net Sales- Laboratory' at $562.82 million. The estimate indicates a change of +4.6% from the prior-year quarter.
View all Key Company Metrics for Mettler-Toledo here>>>
Over the past month, shares of Mettler-Toledo have returned +8.7% versus the Zacks S&P 500 composite's +1.9% change. Currently, MTD carries a Zacks Rank #2 (Buy), suggesting that it may outperform. the overall market in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Bank of Nova Scotia lowered its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 50.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,618 shares of the medical instruments supplier’s stock after selling 3,679 shares during the quarter. Bank of Nova Scotia’s holdings in Mettler-Toledo International were worth $4,563,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Norges Bank acquired a new position in Mettler-Toledo International during the fourth quarter worth $520,989,000. M&T Bank Corp grew its holdings in shares of Mettler-Toledo International by 2,813.6% in the 4th quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock worth $173,165,000 after acquiring an additional 119,942 shares during the period. Capital International Investors raised its holdings in Mettler-Toledo International by 12.7% during the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after purchasing an additional 109,508 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Mettler-Toledo International by 39,107.6% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 61,556 shares of the medical instruments supplier’s stock worth $85,821,000 after purchasing an additional 61,399 shares in the last quarter. Finally, Douglass Winthrop Advisors LLC grew its holdings in Mettler-Toledo International by 4,990.0% in the fourth quarter. Douglass Winthrop Advisors LLC now owns 48,253 shares of the medical instruments supplier’s stock valued at $67,274,000 after purchasing an additional 47,305 shares during the last quarter. 95.07% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes Several research analysts recently issued reports on the company. Wall Street Zen downgraded Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. Citigroup dropped their price objective on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating for the company in a research report on Friday, May 8th. Morgan Stanley reduced their target price on shares of Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 12th. Wolfe Research began coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 2nd. They issued a “peer perform” rating for the company. Finally, Robert W. Baird lowered their target price on shares of Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $1,408.55.
Read Our Latest Research Report on Mettler-Toledo International
Mettler-Toledo International Stock Up 0.6% Shares of Mettler-Toledo International stock opened at $1,335.70 on Tuesday. The business has a 50-day moving average price of $1,212.30 and a 200 day moving average price of $1,276.84. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,525.17. The firm has a market cap of $26.99 billion, a P/E ratio of 31.33, a P/E/G ratio of 2.77 and a beta of 1.24.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million for the quarter, compared to analyst estimates of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the company earned $8.19 earnings per share. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 46.63 earnings per share for the current year.
Mettler-Toledo International Company Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading Five stocks we like better than Mettler-Toledo International AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There? Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECarlisle Companies (CSL) Projected to Release Earnings on Wednesday
NEXT HEADLINE »Caxton Associates LLP Has $689,000 Stock Position in Reliance, Inc. $RS
Dimensional Fund Advisors LP grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 4.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 106,023 shares of the medical instruments supplier’s stock after purchasing an additional 4,340 shares during the period. Dimensional Fund Advisors LP owned about 0.52% of Mettler-Toledo International worth $133,712,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also added to or reduced their stakes in MTD. Whipplewood Advisors LLC bought a new stake in shares of Mettler-Toledo International during the first quarter worth about $25,000. Reflection Asset Management acquired a new stake in Mettler-Toledo International during the 4th quarter worth approximately $26,000. Elyxium Wealth LLC acquired a new stake in Mettler-Toledo International during the 4th quarter worth approximately $29,000. Root Financial Partners LLC grew its holdings in Mettler-Toledo International by 45.5% during the 1st quarter. Root Financial Partners LLC now owns 32 shares of the medical instruments supplier’s stock worth $40,000 after acquiring an additional 10 shares during the last quarter. Finally, DV Equities LLC acquired a new position in Mettler-Toledo International in the 4th quarter valued at approximately $40,000. 95.07% of the stock is currently owned by institutional investors and hedge funds.
Mettler-Toledo International Trading Up 0.6% Shares of Mettler-Toledo International stock opened at $1,335.70 on Tuesday. The business has a 50-day moving average price of $1,212.30 and a two-hundred day moving average price of $1,276.84. Mettler-Toledo International, Inc. has a 1-year low of $1,023.05 and a 1-year high of $1,525.17. The company has a market cap of $26.99 billion, a P/E ratio of 31.33, a PEG ratio of 2.77 and a beta of 1.24.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last announced its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. The company had revenue of $947.13 million for the quarter, compared to the consensus estimate of $943.14 million. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm’s revenue was up 7.2% compared to the same quarter last year. During the same period in the previous year, the business earned $8.19 EPS. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. Equities research analysts forecast that Mettler-Toledo International, Inc. will post 46.63 EPS for the current fiscal year.
Wall Street Analyst Weigh In Several research firms have recently issued reports on MTD. Weiss Ratings downgraded shares of Mettler-Toledo International from a “hold (c)” rating to a “hold (c-)” rating in a research note on Tuesday, July 21st. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Morgan Stanley decreased their price objective on Mettler-Toledo International from $1,475.00 to $1,275.00 and set an “equal weight” rating for the company in a report on Tuesday, May 12th. Robert W. Baird cut their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a report on Monday, May 11th. Finally, Citigroup reduced their price target on Mettler-Toledo International from $1,700.00 to $1,550.00 and set a “buy” rating on the stock in a research report on Friday, May 8th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $1,408.55.
Read Our Latest Analysis on Mettler-Toledo International
Mettler-Toledo International Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
See Also Five stocks we like better than Mettler-Toledo International AirJoule’s Kubota Deal Is a Major Validation—But the Hard Part Comes Next Dividend Stocks May Be the Quiet Rotation Trade Investors Are Missing Now Refiner Stocks Are Near Record Highs—Can Iran-Driven Margins Keep Them There? Verizon May Be an AI Infrastructure Stock Hiding in Plain Sight
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBoston Scientific (NYSE:BSX) Given New $85.00 Price Target at Oppenheimer
NEXT HEADLINE »Dimensional Fund Advisors LP Has $119.58 Million Position in Knife River Corporation $KNF
Mettler-Toledo (MTD - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on July 30. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis maker of precision instruments is expected to post quarterly earnings of $10.78 per share in its upcoming report, which represents a year-over-year change of +6.8%.
Revenues are expected to be $1.03 billion, up 5% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Mettler-Toledo?For Mettler-Toledo, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination makes it difficult to conclusively predict that Mettler-Toledo will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Mettler-Toledo would post earnings of $8.7 per share when it actually produced earnings of $8.91, delivering a surprise of +2.41%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Mettler-Toledo doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
Investors might want to bet on Mettler-Toledo (MTD - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.
The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system.
Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.
As such, the Zacks rating upgrade for Mettler-Toledo is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price.
Most Powerful Force Impacting Stock PricesThe change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. The influence of institutional investors has a partial contribution to this relationship, as these big professionals use earnings and earnings estimates to calculate the fair value of a company's shares. An increase or decrease in earnings estimates in their valuation models simply results in higher or lower fair value for a stock, and institutional investors typically buy or sell it. Their transaction of large amounts of shares then leads to price movement for the stock.
Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Mettler-Toledo imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher.
Harnessing the Power of Earnings Estimate RevisionsAs empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock movements, tracking such revisions for making an investment decision could be truly rewarding. Here is where the tried-and-tested Zacks Rank stock-rating system plays an important role, as it effectively harnesses the power of earnings estimate revisions.
The Zacks Rank stock-rating system, which uses four factors related to earnings estimates to classify stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record, with Zacks Rank #1 stocks generating an average annual return of +25% since 1988. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here >>>> .
Earnings Estimate Revisions for Mettler-ToledoFor the fiscal year ending December 2026, this maker of precision instruments is expected to earn $46.63 per share, which is unchanged compared with the year-ago reported number.
Analysts have been steadily raising their estimates for Mettler-Toledo. Over the past three months, the Zacks Consensus Estimate for the company has increased 0.3%.
Bottom LineUnlike the overly optimistic Wall Street analysts whose rating systems tend to be weighted toward favorable recommendations, the Zacks rating system maintains an equal proportion of "buy" and "sell" ratings for its entire universe of more than 4,000 stocks at any point in time. Irrespective of market conditions, only the top 5% of the Zacks-covered stocks get a "Strong Buy" rating and the next 15% get a "Buy" rating. So, the placement of a stock in the top 20% of the Zacks-covered stocks indicates its superior earnings estimate revision feature, making it a solid candidate for producing market-beating returns in the near term.
You can learn more about the Zacks Rank here >>>
The upgrade of Mettler-Toledo to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its second quarter 2026 financial results after the market close on Thursday, July 30, 2026. The Company will host a conference call the following morning at 7:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company’s website, investor.mt.com.
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
Mettler-Toledo (MTD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
On June 24, 2026, Mettler-Toledo International Inc (MTD) shares rose 4.0% to $1203.18, reflecting a positive shift in market sentiment. Despite today's move, th
Dimensional Fund Advisors LP decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 4.8% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 102,564 shares of the medical instruments supplier's stock after selling 5,160 shares during the period. Dimensional Fund Advisors LP
Banco Bilbao Vizcaya Argentaria S.A. increased its stake in Mettler-Toledo International, Inc. (NYSE: MTD) by 7.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,715 shares of the medical instruments supplier's stock after acquiring an additional 616 shares
Nordea Investment Management AB increased its position in shares of Mettler-Toledo International, Inc. (NYSE: MTD) by 11.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 157,457 shares of the medical instruments supplier's stock after buying an additional 16,777 shares during the period. Nordea
Canoe Financial LP lessened its holdings in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 4.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 53,864 shares of the medical instruments supplier’s stock after selling 2,260 shares during the period. Canoe Financial LP owned about 0.26% of Mettler-Toledo International worth $75,097,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other large investors also recently bought and sold shares of the business. Versant Capital Management Inc raised its stake in shares of Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock worth $33,000 after buying an additional 8 shares during the period. SJS Investment Consulting Inc. grew its stake in Mettler-Toledo International by 2,700.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares during the period. Salomon & Ludwin LLC acquired a new stake in Mettler-Toledo International in the 3rd quarter valued at $43,000. Root Financial Partners LLC purchased a new stake in Mettler-Toledo International in the 3rd quarter worth $42,000. Finally, Quantbot Technologies LP acquired a new position in Mettler-Toledo International during the third quarter worth $49,000. Institutional investors and hedge funds own 95.07% of the company’s stock.
Insider Buying and Selling In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the firm’s stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the transaction, the chief financial officer directly owned 5,288 shares of the company’s stock, valued at $7,456,714.56. This trade represents a 13.14% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 1.94% of the company’s stock.
Analyst Upgrades and Downgrades Several analysts have recently issued reports on the stock. Bank of America upgraded shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 target price on the stock in a research report on Monday, December 15th. Barclays reduced their price target on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective on the stock. Finally, Morgan Stanley cut their price objective on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating for the company in a research note on Tuesday, February 10th. Seven research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $1,463.75.
View Our Latest Analysis on MTD
Mettler-Toledo International Stock Down 2.8% Mettler-Toledo International stock opened at $1,234.22 on Friday. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,525.17. The firm has a market capitalization of $24.99 billion, a price-to-earnings ratio of 29.30, a PEG ratio of 2.58 and a beta of 1.43. The company has a fifty day simple moving average of $1,328.56 and a 200-day simple moving average of $1,364.02.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 earnings per share for the quarter, topping the consensus estimate of $12.76 by $0.60. The firm had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. The company’s revenue for the quarter was up 8.1% on a year-over-year basis. During the same period last year, the firm posted $12.41 earnings per share. On average, research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.
About Mettler-Toledo International (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Further Reading Five stocks we like better than Mettler-Toledo International Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
Aberdeen Group plc grew its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 16.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,756 shares of the medical instruments supplier’s stock after buying an additional 2,862 shares during the period. Aberdeen Group plc owned 0.10% of Mettler-Toledo International worth $28,938,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently modified their holdings of MTD. Principal Financial Group Inc. boosted its position in shares of Mettler-Toledo International by 2.9% during the 3rd quarter. Principal Financial Group Inc. now owns 298,429 shares of the medical instruments supplier’s stock valued at $366,354,000 after acquiring an additional 8,360 shares during the last quarter. Nordea Investment Management AB increased its position in shares of Mettler-Toledo International by 11.9% in the fourth quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock worth $220,718,000 after purchasing an additional 16,777 shares during the last quarter. Corient Private Wealth LLC raised its stake in Mettler-Toledo International by 91.8% in the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after purchasing an additional 67,149 shares in the last quarter. Campbell & CO Investment Adviser LLC bought a new stake in Mettler-Toledo International during the third quarter valued at approximately $2,210,000. Finally, Rakuten Investment Management Inc. bought a new stake in Mettler-Toledo International during the third quarter valued at approximately $121,021,000. 95.07% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the company’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the completion of the transaction, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.94% of the stock is owned by insiders.
Mettler-Toledo International Price Performance NYSE MTD opened at $1,262.02 on Monday. The stock has a market capitalization of $25.56 billion, a PE ratio of 29.96, a PEG ratio of 2.64 and a beta of 1.43. Mettler-Toledo International, Inc. has a 1 year low of $946.69 and a 1 year high of $1,525.17. The business’s 50-day moving average is $1,311.78 and its 200 day moving average is $1,364.50.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 EPS for the quarter, beating analysts’ consensus estimates of $12.76 by $0.60. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business had revenue of $1.13 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the prior year, the company posted $12.41 EPS. Mettler-Toledo International’s quarterly revenue was up 8.1% compared to the same quarter last year. As a group, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.
Analyst Upgrades and Downgrades Several analysts have recently weighed in on the stock. Wells Fargo & Company raised their price objective on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Wall Street Zen raised Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Barclays lowered their price target on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. Jefferies Financial Group raised Mettler-Toledo International from a “hold” rating to a “buy” rating and lifted their price target for the stock from $1,400.00 to $1,450.00 in a research note on Friday, March 20th. Finally, The Goldman Sachs Group began coverage on Mettler-Toledo International in a report on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price objective for the company. Seven equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Mettler-Toledo International currently has an average rating of “Moderate Buy” and a consensus target price of $1,463.75.
Read Our Latest Analysis on MTD
About Mettler-Toledo International (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles Five stocks we like better than Mettler-Toledo International
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAberdeen Group plc Acquires 785,648 Shares of Tectonic Therapeutic, Inc. $TECX
NEXT HEADLINE »Aberdeen Group plc Reduces Stock Holdings in Republic Services, Inc. $RSG
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its first quarter 2026 financial results after the market close on Thursday, May 7, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE: MTD) is a leading globa.
Mettler-Toledo International, Inc. (NYSE:MTD – Get Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen research firms that are currently covering the stock, Marketbeat reports. Six equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $1,463.75.
Several brokerages recently weighed in on MTD. Wall Street Zen raised shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Barclays cut their target price on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research note on Monday, December 15th. Bank of America raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price objective on the stock in a research report on Monday, December 15th. Morgan Stanley dropped their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 10th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a research report on Monday, December 29th.
View Our Latest Analysis on MTD
Insider Activity In related news, CFO Shawn Vadala sold 800 shares of the stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the completion of the sale, the chief financial officer owned 5,288 shares in the company, valued at $7,456,714.56. This represents a 13.14% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.71% of the company’s stock.
Institutional Trading of Mettler-Toledo International Several hedge funds have recently made changes to their positions in MTD. Reflection Asset Management purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $26,000. Elyxium Wealth LLC purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $29,000. Versant Capital Management Inc increased its holdings in Mettler-Toledo International by 42.1% during the 3rd quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after acquiring an additional 8 shares in the last quarter. SJS Investment Consulting Inc. increased its holdings in Mettler-Toledo International by 2,700.0% during the 3rd quarter. SJS Investment Consulting Inc. now owns 28 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 27 shares in the last quarter. Finally, DV Equities LLC purchased a new position in Mettler-Toledo International during the 4th quarter valued at about $40,000. Institutional investors and hedge funds own 95.07% of the company’s stock.
Mettler-Toledo International Stock Up 0.6% MTD stock opened at $1,330.10 on Friday. The stock has a market capitalization of $26.93 billion, a P/E ratio of 31.58, a P/E/G ratio of 2.77 and a beta of 1.43. The firm has a 50-day simple moving average of $1,302.70 and a 200-day simple moving average of $1,363.84. Mettler-Toledo International has a 52 week low of $962.54 and a 52 week high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last posted its quarterly earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 earnings per share for the quarter, topping analysts’ consensus estimates of $12.76 by $0.60. The firm had revenue of $1.13 billion for the quarter, compared to analyst estimates of $1.10 billion. Mettler-Toledo International had a net margin of 21.59% and a negative return on equity of 495.07%. Mettler-Toledo International’s quarterly revenue was up 8.1% on a year-over-year basis. During the same period in the previous year, the business posted $12.41 earnings per share. On average, analysts expect that Mettler-Toledo International will post 42.71 earnings per share for the current year.
Mettler-Toledo International Company Profile (Get Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles Five stocks we like better than Mettler-Toledo International
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINETexas Capital Government Money Market ETF (NYSEARCA:MMKT) Trading 0% Higher – What’s Next?
NEXT HEADLINE »STKD Bitcoin & Gold ETF (NYSEARCA:BTGD) Stock Price Up 1.7% – Here’s Why
Massachusetts Financial Services Co. MA reduced its holdings in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 167,872 shares of the medical instruments supplier’s stock after selling 13,995 shares during the period. Massachusetts Financial Services Co. MA owned about 0.82% of Mettler-Toledo International worth $234,045,000 at the end of the most recent quarter.
Several other institutional investors also recently bought and sold shares of MTD. Rakuten Investment Management Inc. acquired a new stake in Mettler-Toledo International in the third quarter valued at approximately $121,021,000. Alliancebernstein L.P. grew its holdings in Mettler-Toledo International by 10.7% in the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after purchasing an additional 76,478 shares during the period. Corient Private Wealth LLC grew its holdings in Mettler-Toledo International by 91.8% in the second quarter. Corient Private Wealth LLC now owns 140,267 shares of the medical instruments supplier’s stock valued at $164,775,000 after purchasing an additional 67,149 shares during the period. Thrivent Financial for Lutherans grew its holdings in Mettler-Toledo International by 752.2% in the third quarter. Thrivent Financial for Lutherans now owns 73,586 shares of the medical instruments supplier’s stock valued at $90,335,000 after purchasing an additional 64,951 shares during the period. Finally, Bank of America Corp DE grew its holdings in Mettler-Toledo International by 56.8% in the third quarter. Bank of America Corp DE now owns 128,116 shares of the medical instruments supplier’s stock valued at $157,276,000 after purchasing an additional 46,402 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.
Insider Buying and Selling at Mettler-Toledo International In related news, CFO Shawn Vadala sold 800 shares of Mettler-Toledo International stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total transaction of $1,128,096.00. Following the transaction, the chief financial officer owned 5,288 shares in the company, valued at approximately $7,456,714.56. This trade represents a 13.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.71% of the stock is currently owned by company insiders.
Wall Street Analyst Weigh In Several brokerages have commented on MTD. Morgan Stanley dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a report on Tuesday, February 10th. Jefferies Financial Group raised Mettler-Toledo International from a “hold” rating to a “buy” rating and raised their price objective for the company from $1,400.00 to $1,450.00 in a report on Friday, March 20th. Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, December 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 29th. Finally, Barclays decreased their target price on Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating on the stock in a research report on Monday, December 15th. Seven investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $1,463.75.
Check Out Our Latest Research Report on MTD
Mettler-Toledo International Price Performance NYSE MTD opened at $1,323.27 on Monday. The company has a market cap of $26.80 billion, a PE ratio of 31.42, a price-to-earnings-growth ratio of 2.78 and a beta of 1.43. The stock’s 50 day simple moving average is $1,301.75 and its 200-day simple moving average is $1,365.91. Mettler-Toledo International, Inc. has a 1-year low of $962.54 and a 1-year high of $1,525.17.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Friday, February 6th. The medical instruments supplier reported $13.36 earnings per share for the quarter, beating the consensus estimate of $12.76 by $0.60. The business had revenue of $1.13 billion for the quarter, compared to the consensus estimate of $1.10 billion. Mettler-Toledo International had a negative return on equity of 495.07% and a net margin of 21.59%.The business’s quarterly revenue was up 8.1% compared to the same quarter last year. During the same quarter last year, the business posted $12.41 earnings per share. On average, equities research analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.
Mettler-Toledo International Company Profile (Free Report)
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
Featured Articles Five stocks we like better than Mettler-Toledo International Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTD – Free Report).
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEAmazon.com, Inc. $AMZN is Asset Planning Services Inc. LA ADV’s 7th Largest Position
NEXT HEADLINE »Massachusetts Financial Services Co. MA Reduces Position in Equinix, Inc. $EQIX
Key Takeaways Biogen highlights five non-tech wide moat stocks built for durable growth and market resilience.Lockheed Martin benefits from rising defense budgets, strong backlog and sustained F-35 demand globally.Mastercard gains from digital payment adoption, AI integration, and expanding revenue streams. The wide moat strategy involves investing in companies that not only lead their industries but are also strategically fortified to maintain dominance in the future. The business models of these companies possess durable competitive advantages that shield them from competitors. This strategy isn't just about recording short-term gains, but securing a portfolio of stocks that can weather economic storms and deliver stable and predictable returns.
This investment strategy focuses on companies with unique strengths such as brand recognition, patent protection, proprietary technology and network effects. These moats ensure long-term profitability and market leadership, making the companies resilient in volatile markets.
Here we recommend five non-tech Wide Moat stocks with a favorable Zacks Rank. These stocks are: Biogen Inc. (BIIB - Free Report) , Lockheed Martin Corp. (LMT - Free Report) , Northrop Grumman Corp. (NOC - Free Report) , Mastercard Inc. (MA - Free Report) and Mettler-Toledo International Inc. (MTD - Free Report) . Each of our picks carries either a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The chart below shows the price performance of our five picks year to date.
Image Source: Zacks Investment Research
Biogen Inc.Biogen has successfully diversified its pipeline across areas like Alzheimer's, immunology and rare disease. BIIB’s spinal muscular atrophy (SMA) treatment, Spinraza (nusinersen) was the first treatment to be approved in the United States for SMA. Despite increasing competition, Spinraza has held a decent share in most markets.
BIIB’s Leqembi/lecanemab gained approval for early Alzheimer’s disease in the United States in 2023. Though the Leqembi launch was slow, it picked up in 2024 and 2025. Leqembi has also been launched in Japan, China, the EU and some other countries. Leqembi commands over 60% of the anti-amyloid therapy market share in the United States.
BIIB is making significant progress toward building a multi-franchise portfolio through both internal development and collaborations. BIIB is expanding its pipeline portfolio into rare diseases, immunology and neuropsychiatry.
Biogen has an expected revenue and earnings growth rate of -4.7% and 3.2%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
Lockheed Martin Corp.Lockheed Martin’s broad product offerings allow it to secure major defense contracts, which in turn boost its backlog count. LMT remains the largest U.S. defense contractor with a steady order flow from the Pentagon and other allies of the country.
Apart from enjoying a strong forte on the domestic front, LMT’s products are well-acclaimed in the international market. Increasing U.S. defense budget funding should boost its business. LMT continues to witness international interest in the Aegis Ballistic Missile Defense System (Aegis) from international customers, such as Japan, Spain, the Republic of Korea and Australia.
The production of F-35 jets is expected to continue for many years, given the government's current inventory target of 2,470 aircraft for the Air Force, Marine Corps and Navy by 2040 and LMT expecting the global fleet to reach more than 3,500. Consequently, one may expect LMT to witness more order inflows for F-35 in the coming days, which should significantly bolster this defense contractor’s top line.
Lockheed Martin has an expected revenue and earnings growth rate of 5.5% and 29.5%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
Northrop Grumman Corp.Northrop Grumman boasts a solid presence in Defense and Cyber Security programs, with its product line being well-positioned in high-priority categories. NOC witnesses strong demand for its products across the globe. NOC boasts a strong financial position.
The current U.S. government’s inclination toward strengthening the nation’s defense system should benefit NOC. Foreign military sales also serve as a key growth catalyst for Northrop, with the company delivering its products and services to customers in 25 nations. NOC’s international sales totaled $5.99 billion in 2025, comprising 14% of total sales, and improving a solid 19.8% year over year.
Northrop Grumman has an expected revenue and earnings growth rate of 4.6% and 6.7%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
Mastercard Inc.Mastercard’s acquisitions are helping it to increase addressable markets and drive new revenue streams. MA’s net revenue rose16% year over year in 2025. The accelerated adoption of digital and contactless solutions is providing an opportunity for MA’s business to expedite its shift to the digital mode. Strong cash flow supports its growth initiatives.
Mastercard is aggressively adopting AI technologies to enhance security and customer experiences. MA is using AI in five different aspects of its operations — first, fraud detection and prevention, second, optimization of the payment processing services, third, customer experience personalization, fourth, deeper analysis of customer behavior using predictive AI analytics tools and finally the use of high-end AI technologies to enhance merchant services.
Mastercard has an expected revenue and earnings growth rate of 12.7% and 14.8%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.01% in the last seven days.
Mettler-Toledo International Inc.Mettler-Toledo is benefiting from its innovative product portfolio, strong demand for automation solutions and market share gains in product inspection. MTD’s expanded midrange product offerings have attracted new customers, while its bioprocessing-related sales remain strong, supported by unique workflow solutions.
MTD offered positive 2026 guidance, with operating margin expected to be up 60 to 70 basis points, which is flattish to slightly up on a reported basis. Strong liquidity is expected to help MTD continue its share repurchase program. Free cash flow is expected to be approximately $900 million in 2026, representing a 5% increase on a per share basis, with the first quarter expected to be approximately $100 million.
Mettler-Toledo International has an expected revenue and earnings growth rate of 4.9% and 8.9%, respectively, for the current year. The Zacks Consensus Estimate for the current year’s earnings has improved 0.01% in the last 30 days.
COLUMBUS, Ohio--(BUSINESS WIRE)--Mettler-Toledo International Inc. (NYSE: MTD) today announced first quarter results for 2026. Provided below are the highlights:
Reported sales increased 7% compared with the prior year. In local currency, sales increased 3% compared with the prior year reflecting an increase of 1% excluding acquisitions. Net earnings per diluted share as reported (EPS) were $8.33, compared with $7.81 in the prior-year period. Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. First Quarter Results
Patrick Kaltenbach, President and Chief Executive Officer, stated, “We are pleased with our first quarter results as we delivered good performance in an increasingly uncertain market environment. Solid execution of our margin initiatives supported very good Adjusted EPS growth.”
GAAP Results
EPS in the quarter was $8.33, compared with the prior-year amount of $7.81.
Compared with the prior year, total reported sales increased 7% to $947.1 million. By region, reported sales increased 3% in the Americas, 12% in Europe, and 8% in Asia/Rest of World. Earnings before taxes amounted to $209.7 million, compared with $201.9 million in the prior year.
Non-GAAP Results
Adjusted EPS was $8.91, an increase of 9% over the prior-year amount of $8.19.
Compared with the prior year, total sales in local currency increased 3%. By region, local currency sales increased 2% in the Americas, 1% in Europe, and 5% in Asia/Rest of World. Excluding acquisitions, first quarter local currency sales increased 1%, including flat sales in the Americas and 3% growth in Asia/Rest of World. Adjusted Operating Profit amounted to $246.2 million, compared with the prior-year amount of $236.7 million.
Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.
Outlook
Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the second quarter of 2026 will increase approximately 3%. Adjusted EPS is forecast to be $10.70 to $10.85, a growth rate of 6% to 8%.
For the full year 2026, management anticipates local currency sales will increase approximately 4%. Adjusted EPS is forecast to be in the range of $46.30 to $46.95, representing growth of approximately 8% to 10%. This compares with previous local currency sales growth guidance of approximately 4% and Adjusted EPS guidance of $46.05 to $46.70.
The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.
Conclusion
Kaltenbach concluded, “Our investments in innovation continue to provide tangible benefits and also position us strongly to capitalize on our customers’ investments in automation, digitalization, and onshoring in the future. While we recognize increased uncertainty in the macroeconomic environment, we remain confident in our agility and the strong execution of our growth and margin expansion programs to achieve solid Adjusted EPS growth this year.”
Other Matters
The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, May 8) at 8:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company’s website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.
METTLER TOLEDO (NYSE: MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.
Forward-Looking Statements Disclaimer
You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as “may,” “will,” “could,” “would,” “should,” “expect,” “plan,” “anticipate,” “intend,” “believe,” “estimate,” “predict,” “potential,” or “continue.”
We make forward-looking statements in this Quarterly Report about future events or our future financial performance, including sales and earnings growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, share repurchases, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, the impact of inflation, ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, the conflict in Ukraine and continuing instability in the Middle East on our business.
Our forward-looking statements may not be accurate or complete, speak only as of the date of this Quarterly Report, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, inflation, the conflict in Ukraine and continuing instability in the Middle East. See in particular “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2025 and other reports filed with the SEC from time to time.
METTLER-TOLEDO INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS (amounts in thousands except share data) (unaudited) Three months ended Three months ended March 31, 2026 % of sales March 31, 2025 % of sales Net sales $947,127
(a) 100.0
$883,744
(a) 100.0
Cost of sales 391,311
41.3
357,865
40.5
Gross profit 555,816
58.7
525,879
59.5
Research and development 51,275
5.4
46,346
5.2
Selling, general and administrative 258,326
27.3
242,799
27.5
Amortization 19,612
2.1
17,193
2.0
Interest expense 17,007
1.8
16,653
1.9
Restructuring charges 7,270
0.8
3,767
0.4
Other charges (income), net (7,329)
(0.8)
(2,821)
(0.3)
Earnings before taxes 209,655
22.1
201,942
22.8
Provision for taxes 40,201
4.2
38,355
4.3
Net earnings $169,454
17.9
$163,587
18.5
Basic earnings per common share: Net earnings $8.35
$7.84
Weighted average number of common shares 20,286,133
20,868,873
Diluted earnings per common share: Net earnings $8.33
$7.81
Weighted average number of common and common equivalent shares 20,338,274
20,945,188
Note: (a) Local currency sales increased 3% as compared to the same period in 2025.
RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT Three months ended Three months ended March 31, 2026 % of sales March 31, 2025 % of sales Earnings before taxes $209,655
$201,942
Amortization 19,612
17,193
Interest expense 17,007
16,653
Restructuring charges 7,270
3,767
Other charges (income), net (7,329)
(2,821)
Adjusted operating profit $246,215
(b) 26.0
$236,734
26.8
Note: (b) Adjusted operating profit increased 4% as compared to the same period in 2025.
METTLER-TOLEDO INTERNATIONAL INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(amounts in thousands)
(unaudited)
March 31, 2026 December 31, 2025 Cash and cash equivalents $60,574
$66,888
Accounts receivable, net 708,206
778,243
Inventories 404,826
387,228
Other current assets and prepaid expenses 158,305
130,308
Total current assets 1,331,911
1,362,667
Property, plant and equipment, net 830,329
845,636
Goodwill and other intangibles assets, net 1,010,637
1,018,135
Other non-current assets 496,038
486,208
Total assets $3,668,915
$3,712,646
Short-term borrowings and maturities of long-term debt $67,042
$63,931
Trade accounts payable 228,719
266,628
Accrued and other current liabilities 812,600
867,557
Total current liabilities 1,108,361
1,198,116
Long-term debt 2,161,596
2,088,241
Other non-current liabilities 440,841
449,925
Total liabilities 3,710,798
3,736,282
Shareholders’ equity (41,883)
(23,636)
Total liabilities and shareholders’ equity $3,668,915
$3,712,646
METTLER-TOLEDO INTERNATIONAL INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (amounts in thousands) (unaudited) Three months ended March 31, 2026
2025
Cash flow from operating activities: Net earnings $169,454
$163,587
Adjustments to reconcile net earnings to net cash provided by operating activities: Depreciation 13,160
12,464
Amortization 19,612
17,193
Deferred tax provision (benefit) (1,994)
(879)
Share-based compensation 5,469
5,139
Proceeds from government grant (a) 6,240
-
Decrease in cash resulting from changes in operating assets and liabilities (72,147)
(3,055)
Net cash provided by operating activities 139,794
194,449
Cash flows from investing activities: Purchase of property, plant and equipment (17,414)
(17,255)
Acquisitions (2,242)
-
Other investing activities (11,692)
10,348
Net cash used in investing activities (31,348)
(6,907)
Cash flows from financing activities: Proceeds from borrowings 513,590
512,496
Repayments of borrowings (420,104)
(479,326)
Proceeds from exercise of stock options 620
2,198
Repurchases of common stock (206,250)
(218,749)
Acquisition contingent consideration paid (2,190)
-
Other financing activities -
(764)
Net cash used in financing activities (114,334)
(184,145)
Effect of exchange rate changes on cash and cash equivalents (426)
1,532
Net increase in cash and cash equivalents (6,314)
4,929
Cash and cash equivalents: Beginning of period 66,888
59,362
End of period $60,574
$64,291
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
Three months ended March 31, 2026
2025
Net cash provided by operating activities $139,794
$194,449
Payments in respect of restructuring activities 3,436
2,566
Payments for acquisition transaction costs 137
-
Proceeds from government grant (a) (6,240)
-
Purchase of property, plant and equipment, net (17,414)
(17,255)
Adjusted free cash flow $119,713
$179,760
METTLER-TOLEDO INTERNATIONAL INC. OTHER OPERATING STATISTICS SALES GROWTH BY DESTINATION (unaudited) Americas Europe Asia/RoW
Total U.S. Dollar Sales Growth Three Months Ended March 31, 2026 3%
12%
8%
7%
Local Currency Sales Growth Three Months Ended March 31, 2026 2%
1%
5%
3%
Note: (a) Net sales in local currency excluding acquisitions grew 1%, including flat sales in the Americas and 3% sales growth in Asia/Rest of World, for the three months ended March 31, 2026. RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS (unaudited) Three months ended March 31, 2026
2025
% Growth EPS as reported, diluted $8.33
$7.81
7%
Purchased intangible amortization, net of tax 0.27
(a) 0.23
(a) Restructuring charges, net of tax 0.29
(b) 0.15
(b) Income tax expense 0.02
(c) -
Adjusted EPS, diluted $8.91
$8.19
9%
Notes: (a) Represents the EPS impact of purchased intangibles amortization of $7.1 million ($5.4 million after tax) and $6.3 million ($4.9 million after tax) for the three months ended March 31, 2026 and 2025, respectively. (b) Represents the EPS impact of restructuring charges of $7.3 million ($5.9 million after tax) and $3.8 million ($3.1 million after tax) for the three months ended March 31, 2026 and 2025, respectively, which primarily include employee related costs. (c) Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three months ended March 31, 2026 due to the timing of excess tax benefits associated with stock option exercises. More News From Mettler-Toledo International Inc.
Mettler-Toledo (MTD - Free Report) came out with quarterly earnings of $8.91 per share, beating the Zacks Consensus Estimate of $8.7 per share. This compares to earnings of $8.19 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of +2.44%. A quarter ago, it was expected that this maker of precision instruments would post earnings of $12.76 per share when it actually produced earnings of $13.36, delivering a surprise of +4.7%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Mettler-Toledo, which belongs to the Zacks Medical - Instruments industry, posted revenues of $947.13 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 0.04%. This compares to year-ago revenues of $883.74 million. The company has topped consensus revenue estimates four times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Mettler-Toledo shares have lost about 4.8% since the beginning of the year versus the S&P 500's gain of 7.6%.
What's Next for Mettler-Toledo?While Mettler-Toledo has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Mettler-Toledo was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $11.04 on $1.03 billion in revenues for the coming quarter and $46.51 on $4.22 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Instruments is currently in the bottom 41% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the same industry, PAVmed Inc. (PAVM - Free Report) , has yet to report results for the quarter ended March 2026. The results are expected to be released on May 15.
This company is expected to post quarterly loss of $0.69 per share in its upcoming report, which represents a year-over-year change of +67.1%. The consensus EPS estimate for the quarter has been revised 82.2% higher over the last 30 days to the current level.
PAVmed Inc.'s revenues are expected to be $0.1 million, up 900% from the year-ago quarter.
Although the revenue and EPS for Mettler-Toledo (MTD) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
MarketBeat Instant News Alerts Trending News All MarketBeat Instant News Alerts Sort By
Time Frame
Alert Type
Keywords
Page 1 of 324
Get 30 Days of MarketBeat All Access for Free
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.
Start Your 30-Day Trial
Sign in to your free account to enjoy these benefits
In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer.
On May 18, 2026, Mettler-Toledo International Inc (MTD) shares rose 4.2%, closing at $1074.84. The stock has experienced significant volatility, trading within
